Find stats on top websites

Business and Product Insights

Product Portfolio

Qdata Diabetic Retinopathy

MIPS Advisory Services

Site Explorer by Verana Health

Verana Health Key Value Propositions

Verana Health provides exclusive access to vast, high-quality, de-identified real-world EHR data, powered by AI, to accelerate drug development and improve patient care. This unique access enables life sciences and CROs to gain deeper clinical nuance for more effective research and commercialization strategies.

Real-World Data Insights
Clinical Trial Acceleration
Exclusive Data Partnerships
AI-Powered Analytics

Verana Health Brand Positioning

Verana Health positions itself as the leader in real-world data and AI-powered analytics, exclusively partnering with medical societies to transform patient care and accelerate clinical research for life sciences and CROs, leveraging deep EHR insights.

Top Competitors

1

Flatiron Health

2

IQVIA

3

TriNetX

Customer Sentiments

Customer sentiment appears positive, as Verana Health addresses critical pain points for life sciences companies, CROs, and clinicians by offering solutions to accelerate research, improve trial efficiency, and streamline quality reporting through high-quality RWD.

Actionable Insights

Highlighting the exclusive data partnerships and the depth of EHR insights, including unstructured notes, will further differentiate Verana Health from competitors.

Products and Features

Qdata Diabetic Retinopathy - Product Description

Qdata Diabetic Retinopathy is an exclusive dataset provided by Verana Health, focusing on a detailed view of the patient journey for Diabetic Macular Edema (DME), Anti-VEGF treatments, and other related treatment details. This dataset likely aggregates real-world data to provide insights into patient progression, treatment patterns, and outcomes within the diabetic retinopathy and DME landscape. It is designed to offer a comprehensive understanding of the patient experience from diagnosis through various stages of treatment, including the use of Anti-VEGF therapies, which are crucial for managing DME.

Pros

  • This dataset provides a detailed and exclusive view of the patient journey for Diabetic Macular Edema, offering deep insights into treatment patterns
  • It is invaluable for research, clinical trials, and healthcare strategy development related to diabetic retinopathy
  • The focus on Anti-VEGF and treatment details allows for granular analysis of therapeutic efficacy and patient response.

Cons

  • The description does not specify the recency or frequency of data updates, which could impact its utility for rapidly evolving medical fields
  • The dataset's exclusivity might limit its accessibility or involve higher costs compared to more generalized datasets
  • Without further information, the geographical scope and patient demographics covered by the data are unclear, potentially limiting its generalizability.

Alternatives

  • Competitors or alternatives include large electronic health record (EHR) data aggregators like Optum or IQVIA, which offer broad healthcare datasets
  • Academic institutions and research organizations also compile and provide specialized medical datasets
  • Other data providers might offer real-world evidence (RWE) platforms focusing on ophthalmology or specific disease areas.

Company Updates

Latest Events at Verana Health

Verana Health

Verana Health is assembling the largest clinical databases in medicine to empower physicians and accelerate research for patients.

View source

Verana Health | LinkedIn

Feb 14, 2022 ... VeraQ and Qdata power the data analytics Verana Health conducts for Life Sciences–including for the top 4 of 5 pharmaceutical companies–and ...

View source

2023 Year in Review from Verana Health's CEO | veranahealth.com

Dec 21, 2023 ... Sujay Jadhav, CEO · Delivering Data on Demand · Partnering with Clinicians to Improve Quality of Care · Powering Site Selection · Linking New Data.

View source

AAO and Verana Health Accelerate Clinical Trials for Patients with ...

Oct 9, 2019 ... https://eyewire.news/articles/aao-and-verana-health-accelerate ... Parke, II, MD, CEO, of the American Academy of Ophthalmology, said in a company ...

View source

Transform Your Ideas into Action in Minutes with WaxWing

Sign up now and unleash the power of AI for your business growth